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Introduction
The ganglioneuroma (GN) is a rare and benign tumor of the sympathetic nervous system, originating from the neural crest, from undifferentiated cells. It is more often found in the chest, but it may also arise in the adrenal gland. It may vary clinically, but the most common associated symptoms are compression of surrounding structures which, in most cases, are detected in routine examinations.
Case report
The authors report the case of a female patient, 65 years of age, referred to a cardiology appointment due to hypertension with about 10 years of development, not controlled with a combination of antihypertensive drugs. The patient reported headaches, malaise, and facial flushing, symptoms that coincided with peak blood pressure (maximum of 190 mmHg systolic blood pressure (BP) and 120 mmHg of diastolic BP), which recently had worsened in terms of frequency and duration. She had been taking indapamide 1.5 mg (1×day), ramipril 5 mg (1×day) and hydrochlorothiazide 12.5 mg (1×day).
As for personal history, she reported an appendectomy at age 17 and a laparoscopic cholecystectomy at age 53. She has never been a smoker or drinker. Her family history was irrelevant and was negative for endocrine neoplasia.
On physical examination, cushingoid characteristics or signs of virilization were not found. Cardiopulmonary auscultation was normal, as well as the remaining examination.
The electrocardiogram showed normal sinus rhythm and chest radiograph revealed no mediastinal widening, increased cardiothoracic ratio or pleuroparenchymal alterations. Abdominal ultrasound revealed "increased dimensions of the right adrenal gland (3.5 x 2cm) of heterogeneous echotexture, outlining some calcifications and no other abnormalities." Then, the patient underwent abdominal computed tomography (CT) to clarify the abnormalities mentioned (Fig. 1) , which confirmed the presence of a "nodular formation in the right adrenal gland, with microcalcifications of solid density with about 34 mm in diameter." Ambulatory blood pressure monitoring during 24h (ABPM) revealed maximum systolic BP of 160 mmHg and maximum diastolic BP of 90 mmHg with nondipper pattern (Fig. 2) . In laboratory tests, there was an increase in serum aldosterone (798 µmol/l, normal: 28 to 443 µmol/l) with serum renin, plasma metanephrines, cortisol, vanillylmandelic acid and ionogram within normal parameters (1 st analytical determination performed).
She was admitted to the Cardiology Department to study the picture. During hospital admission, a new laboratory study was performed: serum aldosterone and renin, potassium and sodium in urine and serum, measurement of urinary vanillylmandelic acid, plasma and urine metanephrines, thyroid function, erythrocyte sedimentation rate, C-reactive protein, plasma and urinary cortisol. All of these tests proved to be within normal parameters. The echocardiogram showed abnormalities in left ventricular relaxation, with no other abnormalities (normal wall thickness and systolic function). Meta-iodobenzylguanidine scintigraphy ( 123 I-MIBG) revealed no overactive areas over adrenal glands.
During this period, the patient showed some blood pressure peaks associated with headache and malaise, despite therapy with four antihypertensive drugs (1.5 mg indapamide (1×day), 5 mg ramipril (1×day), 12.5 mg hydrochlorothiazide (1×day) and 6.25 mg carvedilol (2×day)).
As it was not possible to deliver a definitive diagnosis through imaging examinations, it was decided to excise the tumor, so the patient underwent laparoscopic unilateral adrenalectomy. The procedure took place without significant complications (there was a transient peak blood pressure during the excision of the adrenal gland).
From the standpoint of pathology, the surgical specimen was described macroscopically as a well-defined lesion, 4 cm in its largest diameter, whitish, with elastic consistency and fasciulate appearance; Schwann cells, ganglion cells, and fibrous and nervous tissue were microscopically detected, with no evidence of immature cells, atypia or necrosis. In view of these findings, the patient was diagnosed with a mature type of ganglioneuroma.
Upon six months of follow-up, the patient is asymptomatic and blood pressure controlled with two antihypertensive drugs (ramipril and hydrochlorothiazide). The patient underwent a new ABPM (Fig. 2 ) and abdominal CT (Fig. 1) which confirmed the success of the surgery and no recurrence.
Discussion
T h e g a n g l i o n e u r o m a b e l o n g s t o t he group of neuroblastic tumors, together with neuroblastoma (NB) and ganglioneuroblastomas (GNB). These are often primary tumors progressing to mature tumors or, more rarely, they can differentiate from a NB or GNB (secondary ganglioneuroma) or from metastatic lesions. Association with other tumors may often occur, such as pheochromocytomas 1 . GN are tumors that arise from places where there is sympathetic nervous tissue, and its most frequent location is the posterior mediastinum, retroperitoneum, adrenal gland and neck, unusual places include the heart, bone and gut. They are more commonly found in women and may appear in all age groups. However, they are more often diagnosed in adolescents and young adults Computed tomography and magnetic resonance imaging are baseline diagnosis methods 1 . However, only one histopathological examination can confirm the diagnosis of ganglioneuroma and to distinguish it from its malignant relatives (neuroblastoma and ganglioneuroblastoma) 5 . GN are tumors composed of mature Schwann cells, ganglion cells, fibrous tissue and nervous tissue, not containing neuroblasts. The three tumors are radiologically indistinguishable but the presence of metastases is suggestive of malignancy. Pathologically, the GN are well-distinguished tumors with well-defined limits, containing a pseudocapsule, often with areas of calcification. When the location is retroperitoneal or adrenal, discrete calcifications may occur in 42% to 60% of the cases; usually growing in the vicinities of blood vessels, vascular invasion or compression is rare 1 .
Radin et al studied nine cases of ganglioneuroma; imaging characterization revealed a mass with regular borders, well-defined, which may be surrounded by blood vessels without compromising its lumen. Evaluation by CT revealed a homogeneous mass, often with calcifications 6 . Just like the GNB and NB, GN may accumulate meta-iodobenzyl-guanidine (MIBG), an analogue of catecholamines used to identify tumors that produce catecholamines such as pheochromocytoma, carcinoid tumors and medullary thyroid carcinoma. GN are tumors that typically have little or no metabolic activity, and MIBG uptake does not distinguish the different histologic types (particularly the 131 I-MIBG 7 ). Geoerger et al, in an analysis of 49 patients with primary ganglioneuroma, reported that 57% of tumors had detectable uptake of MIBG, even those too small, and 39% of patients had increased serum levels of catecholamines 8 .
Treatment depends on various factors like lesion size, picture of endocrine dysfunction and presence of metastases. In most cases, a complete surgical resection allows analyzing the specimen and determining a diagnosis. An analysis conducted by Hayes et al 7 revealed that these tumors are consistent with a prolonged disease-free survival even when excision is not possible 7 . In rare cases, tumor recurrence may arise. Clinical and imaging follow-up for long periods are important measures.
In our case, the final diagnosis was a mature ganglioneuroma compatible with intermittent secretion of catecholamines. Therapy with multiple antihypertensive drugs may lead to false negative results for the secretion of catecholamines and their metabolites, which may also affect the uptake of MIBG. The surgery, which consisted of a complete excision of the tumor, had a single complication, which was a transient peak blood pressure. In addition, it was healing and led to the disappearance of hypertensive crises and associated symptoms. The clinical and radiological follow-up upon six months revealed no recurrence of the mass or evidence of metastases.
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